TD Asset Management’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Sell
38,458
-16,368
-30% -$495K ﹤0.01% 1044
2026
Q1
$1.55M Sell
54,826
-65,422
-54% -$1.75M ﹤0.01% 1019
2025
Q4
$3.34M Buy
120,248
+15,892
+15% +$383K ﹤0.01% 875
2025
Q3
$2.6M Buy
104,356
+4,846
+5% +$107K ﹤0.01% 909
2025
Q2
$1.75M Buy
99,510
+21,388
+27% +$345K ﹤0.01% 970
2025
Q1
$1.23M Buy
78,122
+22,906
+41% +$386K ﹤0.01% 1048
2024
Q4
$1.06M Buy
55,216
+19,000
+52% +$391K ﹤0.01% 1104
2024
Q3
$671K Sell
36,216
-49,600
-58% -$906K ﹤0.01% 1259
2024
Q2
$1.61M Sell
85,816
-26,800
-24% -$545K ﹤0.01% 1063
2024
Q1
$2.6M Buy
+112,616
New +$2.99M ﹤0.01% 935

Other funds holding PHVS

TD Asset Management's PHVS Position: Q2 2026 in Review

TD Asset Management reduced its Pharvaris (PHVS) stake by 30% in Q2 2026, selling an estimated $495K and leaving 38,458 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1044.

TD Asset Management first reported a position in PHVS in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.34M in Q4 2025. 23 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • TD Asset Management held 38,458 shares of Pharvaris worth $1.33M as of Q2 2026.
  • TD Asset Management sold 16,368 Pharvaris shares in Q2 2026, an estimated $495K.
  • Pharvaris made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #1044 holding.
  • TD Asset Management first reported a position in Pharvaris in Q1 2024 and has held it in 10 quarters since.
  • TD Asset Management's Pharvaris position peaked at $3.34M in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.